8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This protocol is a Phase 2 multi-site study which aims to evaluate the safety and
effectiveness of MYDAYIS® as adjunctive therapy for adults with bipolar depression.
Results from this study WILL NOT be used to contribute to an approval of MYDAYIS ® for
this indication.